PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,775.00
Bid: 1,771.00
Ask: 1,771.50
Change: -8.50 (-0.48%)
Spread: 0.50 (0.028%)
Open: 1,773.50
High: 1,779.00
Low: 1,764.50
Prev. Close: 1,783.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-European stocks slip after four-day run, U.S. tariffs hit Airbus

Thu, 13th Aug 2020 09:39

(For a live blog on European stocks, type LIVE/ in an Eikon
news window)

* FTSE 100 leads declines on ex-dividend trading

* Investors confident of imminent U.S. stimulus - analysts

* Thyssenkrupp slides on flagging losses in steel unit

* Danish brewer Carlsberg falls on sales warning in key
markets
(Adds comments; updates prices)

By Sruthi Shankar and Sagarika Jaisinghani

Aug 13 (Reuters) - European stocks fell on Thursday as
simmering tensions between the United States and China, and
elusive U.S. fiscal stimulus, pushed investors to book profits
after four straight sessions of gains, while Airbus dipped as
Washington left aircraft tariffs unchanged.

The pan-European STOXX 600 was off 0.4%, with
Airbus sliding 1.2% after the U.S. government said it
would maintain 15% tariffs on planes and 25% tariffs on other
European goods, despite moves to resolve a long-standing dispute
over aircraft subsidies.

London's FTSE 100 was at the front of declines among
major European bourses, led by AstraZeneca, BP,
Diageo, Glaxosmithkline and Legal&General
, which traded without entitlement to a dividend payout.

Still, with the U.S. S&P 500 index within striking
distance of a record high, analysts said there were few cues for
global equities to pull back, with investors also disregarding
U.S-China angst.

"There's no stopping this market at the moment," said
Michael Baker, an analyst at ETX Capital.

"There's not a lot negative sentiment (and) the market is
fairly confident that a U.S. stimulus deal will be reached even
if it's a last minute one."

U.S. Democrats and Republicans remain deadlocked after weeks
of wrangling over a fifth coronavirus aid bill. President Donald
Trump on Wednesday accused congressional Democrats of not
wanting to negotiate because he was refusing to go along with
"ridiculous" spending requests unrelated to the pandemic.

In Europe, the STOXX 600 is still about 14% below its
all-time high as data points to a slower-than-expected rebound
from the pandemic. A survey on Thursday showed German companies
expect business to return to normal in an average of 11 months,
with the number even higher for firms in the services sector.

Struggling conglomerate Thyssenkrupp plunged 13.1%
after it said its steel unit would rack up 1 billion euros ($1.2
billion) in operating losses this year, raising pressure to fix
or sell the division. The stock is on course for its biggest
one-day decline in three months.

Danish brewer Carlsberg slid 4.7% on warning that
lockdowns will impact sales in the second half of the year in
its key markets of China and Western Europe.

TUI, the world's largest tourism company, fell 3.0%
as it sunk to a 1.1 billion euro ($1.30 billion) loss in the
third quarter due to the COVID-19 pandemic.
(Reporting by Sruthi Shankar in Bengaluru; Additional reporting
by Sagarika Jaisinghani; Editing by Arun Koyyur, Bernard Orr)

More News
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.